This clinical practice guideline was created to improve patient care by outlining the appropriate information-gathering and decisionmaking processes involved in managing the diagnosis of carpal tunnel syndrome. The methods used to develop this clinical practice guideline were designed to combat bias, enhance transparency, and promote reproducibility. The guideline's recommendations are as follows: The physician should obtain an accurate patient history. The physician should perform a physical examination of the patient that may include personal characteristics as well as performing a sensory examination, manual muscle testing of the upper extremity, and provocative and/or discriminatory tests for alternative diagnoses. The physician may obtain electrodiagnostic tests to differentiate among diagnoses. This may be done in the presence of thenar atrophy and/or persistent numbness. The physician should obtain electrodiagnostic tests when clinical and/or provocative tests are positive and surgical management is being considered. If the physician orders electrodiagnostic tests, the testing protocol should follow the American Academy of Neurology/American Association of Neuromuscular and Electrodiagnostic Medicine/American Academy of Physical Medicine and Rehabilitation guidelines for diagnosis of carpal tunnel syndrome. In addition, the physician should not routinely evaluate patients suspected of having carpal tunnel syndrome with new technology, such as magnetic resonance imaging, computed tomography, and pressure-specified sensorimotor devices in the wrist and hand. This decision was based on an additional nonsystematic literature review following the face-to-face meeting of the work group.
Overview and Rationale
This clinical practice guideline was approved by the American Academy of Orthopaedic Surgeons (AAOS) in May 2007. The AAOS created this clinical practice guideline to improve patient care by outlining the appropriate information-gathering and decision-making processes involved in managing the diagnosis of carpal tunnel syndrome (CTS). Many Americans experience symptoms of CTS and expect relief from the condition, which can be accomplished only with proper diagnosis. If the CTS is diagnosed early, we expect better results of treatment.
For the purpose of this guideline, CTS is defined as a symptomatic compression neuropathy of the median nerve at the level of the wrist, characterized physiologically by evidence of increased pressure within the carpal tunnel and decreased function of the nerve at that level. CTS can be caused by many different diseases, conditions and events. It is characterized by patients as producing numbness, tingling, hand and arm pain and muscle dysfunction. The disorder is not restricted by age, sex, ethnicity, or occupation and is associated with or caused by systemic disease and local mechanical and disease factors.
The AAOS clinical practice guidelines are developed using evidencebased methods, and the recommendations in them are based on systematic reviews of the available literature. The purpose of systematically performing a review is to combat bias. Substantial documentation accompanies the guideline to ensure that the recommendations are, indeed, unbiased. Ideally, those who wish to perform an "intellectual audit" of a guideline can examine this documentation and independently arrive at the same recommendations.
Because systematic reviews combat bias, the studies included in them are not chosen on the basis of whether they were published by an expert. Similarly, the physician work group members who prepared this guideline did not begin work on it by exchanging articles from their personal files. Rather, articles were identified using comprehensive searches of several electronic databases and were included in the guideline only when they met specific criteria that were developed before work on the guideline began.
To further combat bias, the information extracted from published articles did not include the conclusions of the articles' authors (who, themselves, might be biased). Rather, the focus of the guideline and the systematic review upon which it is based is on the data and how they were collected. Thus, information for the guideline was principally derived from information contained in an article's Methods and Results sections. A total of 224 full articles were reviewed for this guideline, 24 of which were ultimately concluded.
These systematic reviews were conducted between August 2006 and March 2007. They identify good evidence as well as circumstances in which evidence is lacking. They also identify topics for future research to improve the treatment of patients with osteoarthritis of the knee. AAOS staff and the Carpal Tunnel Syndrome Guideline Work Group systematically reviewed the available literature and subsequently wrote the following recommendations based on a rigorous, standardized process.
Musculoskeletal care is provided in many different settings by many different providers. We created this guideline as an educational tool to guide qualified physicians through a series of treatment decisions in an effort to improve the quality and efficiency of care. This guideline should not be construed as including all proper methods of care or excluding methods of care reasonably directed to obtaining the same results. The ultimate judgment regarding any specific procedure or treatment must be made in light of all circumstances presented by the patient and the needs and resources particular to the locality or institution.
Methods
The methods used to develop this clinical practice guideline were designed to combat bias, enhance transparency, and promote reproducibility. Their purpose is to allow interested readers the ability to inspect all of the information the work group used to reach all of its decisions and to verify that these decisions are in accord with the best available evidence. The draft of this guideline was subject to peer review and public commentary, and it was approved by the AAOS EvidenceBased Practice Committee; Guidelines and Technology Committee; Council on Research, Quality Assessment and Technology; and the Board of Directors. The methods used to prepare this guideline are detailed in the full clinical practice guideline, which is available at http:// www.aaos.org/research/guidelines/C TS_guideline.pdf. Grade of Recommendation: C Obtaining a history relating to CTS serves to assist in diagnosing the disease and planning appropriate treatment options. A high level of evidence is not available in the literature to assess the diagnostic utility of history data and the predictive value of the data in evaluating severity of disease and outcomes of treatment. Therefore, the work group employed expert opinion in creating this recommendation to guide physicians in the appropriate questions that should be asked during patient encounters to improve diagnosis.
Grading the Recommendations
It is unclear from the literature whether the duration of symptoms correlates with the amount of nerve injury or can predict treatment outcomes. It is also unclear whether the severity and character of symptoms are related to the structural and physiologic condition of the median nerve. The evidence from available studies does not illustrate a direct relationship between symptoms and electrodiagnostic test results either across all studies (regardless of design) or by looking at results for a single electrodiagnostic test. Symptoms such as numbness along the distribution of the median nerve, increasing symptoms at night when sleeping, improvement of symptoms by shaking the hand, and symptom exacerbation when driving or holding a telephone are classic symptoms that in combination may be highly suggestive of CTS.
Identification of the location and radiation of symptoms may exclude or include other diagnoses, such as proximal nerve compression syndrome, that may mimic CTS. Having these associated symptoms may alert the physician to look for diagnoses other than CTS.
The symptoms of CTS may vary on a daily basis. Understanding the disease progression can be helpful in determining the appropriate diagnosis and treatment plan. For symptoms that are not increasingly severe but vary periodically, conservative management may be helpful in diagnosis.
Understanding patient response to previous treatment may verify the diagnosis of CTS and may support patient progression to carpal tunnel surgery. Response to conservative treatment varies. If the physician uses steroid injection, the greatest patient improvement is seen at 1 month. If the physician uses conservative management and measures improvement with electrodiagnostic tests, the greatest improvement is between 3 and 6 months, as seen by change in distal motor latency measurements (ms) (Figure 102 in the Clinical Guideline 2 ). In summary, the work group used expert opinion to formulate Recommendation 1 for obtaining appropriate history to make the diagnosis of CTS. Based on the level of evidence for the studies that reviewed conservative management, the work group rates this recommendation at a C level, which indicates poor quality of evidence consisting of level II, III, or IV data for or against recommending intervention (Table 12 3 and Figure 8 2 in the Clinical Guideline).
Recommendation 2: Physical Examination
The physician should perform a physical examination of the patient that may include Level of Evidence: V Grade of Recommendation: C Personal characteristics such as age, sex, height, weight, and body habitus are basic information that are important for fulfilling the evaluation and management documentation. Included in parts of this evaluation would be determination of vascular status, obvious deformity, and testing for other related conditions (eg, basilar thumb arthritis, de Quervain disease, cubital tunnel syndrome, cervical radiculopathy).
Sensory examination using, for example, two-point discrimination, Semmes-Weinstein monofilament, vibrometry, and texture discrimination, is important for defining the anatomic distribution of sensory changes. Sufficient evidence does not exist from the literature reviewed for this guideline to recommend one test over another or to suggest the overall utility of a test in diagnosing CTS. Future research will be required to confirm the diagnostic utility of these tests.
Manual muscle testing of the upper extremity, including evaluation for obvious muscle atrophy, is important, especially for the thenar muscle area. Thenar atrophy has been reported to have a high predictive value in CTS, but its appearance can be rare. 4 This literature review contained only two primary studies 4, 5 that specifically addressed thenar atrophy. No conclusion on the diagnostic value of thenar atrophy can be drawn conclusively from two studies.
Several provocative tests should be considered to aid in the evaluation and diagnosis of CTS. For multiple reasons (ie, poor study design, variability in study results, inconsistent data, few studies examining the same tests, small datasets for each test), no one test has been identified as a gold standard for identifying CTS. Phalen test results ranged in sensitivity from 0.46 to 0.80 and in specificity from 0.51 to 0.91. [5] [6] [7] [8] The Tinel sign ranged in sensitivity from 0.28 to 0.73 and in specificity from 0.44 to 0.95. [4] [5] [6] [7] The median nerve compression test ranged in sensitivity from 0.04 to 0.79 and in specificity from 0.25 to 0.96. 5, 8, 9 Combining the results of more than one provocative test might increase the sensitivities and specificities. For example, combined results of the Phalen and median nerve compression tests yielded a sensitivity of 0.92 and a specificity of 0.92; 8 however, further literature would be required to confirm whether this result is diagnostically accurate.
The reverse Phalen test, tethered median nerve stress test, and the tourniquet test have been evaluated only a few times, leaving insufficient evidence from which to draw any conclusions as to their accuracy in the diagnosis of CTS. [4] [5] [6] The clinical tests for CTS by themselves do not reliably diagnose CTS. Similarly, as will be discussed in Recommendation 3, electrodiagnos-tic studies by themselves also do not reliably diagnose CTS. However, when the symptoms, clinical tests, and electrodiagnostic tests are combined, statistical significance (P < 0.05) is obtained compared with postsurgical outcomes. Among surgical candidates, clinical tests and electrodiagnostic studies correlated with positive postsurgical outcomes (Figures 96 
Recommendation 3: Nerve Conduction Velocity Studies Recommendation 3.1a
The physician may obtain electrodiagnostic tests to differentiate among diagnoses.
Recommendation 3.1b
The physician may obtain electrodiagnostic tests in the presence of thenar atrophy and/or persistent numbness.
Level of Evidence: V Grade of Recommendation: C There were no prospective studies that evaluated a broad spectrum of patients. In addition, there was no consistent independent reference standard (including atrophy and persistent numbness) used across studies, and none attempted to differentiate CTS from other diagnoses. There were multiple studies differentiating CTS patients from normal subjects, mainly as case-control or cohort studies ( Figures 5 and 9 in the Clinical Guideline 2 ). There were considerable problems with spectrum bias and lack of a gold standard for diagnosis. Thus, the quality of studies fell to level V, or expert opinion. Despite this, there was expert opinion that, in some cases, NCV studies and needle EMG can differentiate CTS from other peripheral nerve problems (eg, polyneuropathy, brachial plexopathy, cervical radiculopathy). Additionally, thenar atrophy and/or persistent numbness may suggest severe nerve injury, which may warrant more aggressive management or diagnostic evaluation. NCV study and EMG can assist in documenting this severe nerve injury. . There were no other high-quality studies that attempted to correlate outcomes of other treatments (eg, splinting, steroid injections) with pretreatment diagnostic results. Good response to surgery does not prove the diagnosis of CTS because other factors may provide symptom relief (eg, placebo, surgery activity modification, postoperative splinting). However, postsurgical improvement is a clinically relevant outcome. Clinicians who are considering surgical management should know that good surgical outcome is correlated with a combination of positive clinical and positive electrodiagnostic tests. [10] [11] [12] [13] [14] Again, it is important to note that the evidence shows a statistically significant association be- . The literature does not permit calculation of sensitivities and specificities of all tests. Additionally, sensitivity and specificity of NCV studies cannot be determined with absolute certainty primarily because a diagnosis of CTS cannot be made with absolute certainty without a gold standard. The lack of a reliable gold standard and the use of reference standards that are variable from study to study give disparate results. Further, no universally agreed-upon diagnostic criteria exist for the diagnosis of CTS. The case-control studies for electrodiagnostic testing consistently showed receiver operating curves of a very high specificity and variable sensitivity ( Figure 11 in the Clinical Guideline 2 ), illustrating inflated results due to spectrum bias.
The case-control studies are, therefore, not considered useful.
Few well-designed cross-sectional and cohort studies were found. Based on the low availability of quality studies as well as the small size of the study populations, statistically significant receiver operating curves 1 could not be constructed.
Recommendation 3.2
If the physician orders electrodiagnostic tests, the testing protocol should follow the American Academy of Neurology/American Association of Neuromuscular and Electrodiagnostic Medicine/American Academy of Physical Medicine and Rehabilitation (AAN/ AANEM/AAPMR) guidelines for diagnosis of CTS.
a. Sensory NCV studies to the median nerve with distal latency compared to the ulnar and radial nerve b. Median motor nerve conduction in most patients c. Needle EMG at the discretion of the physician Levels of Evidence: IV and V Grade of Recommendation: C Thirteen published studies were evaluated and met criteria for review compared with a reference standard of signs, symptoms, and one electrodiagnostic test. Twelve of these studies [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] were level IV and one 27 was level II. The reference standard used included signs, symptoms, and a different electrodiagnostic test than the electrodiagnostic test being evaluated in the study. The index test could not be part of the referenced standard, and vice versa. These inclusion criteria were comparable but slightly different from the criteria used in the AANEM Practice Parameter, which the work group agreed to use as a protocol for electrodiagnostic testing. The AANEM reference standard included clinical symptoms and did not include another nerve conduction study. 28 The vast majority of studies were of case-control design, suggesting spectrum bias. A result of spectrum bias is that the sensitivities and specificities are likely inflated. Multiple nerve conduction studies were reported in the primary articles. These articles employed 11 different nerve conduction study techniques ( Figure  6 in the Clinical Guideline 2 ), including median sensory to ulnar sensory comparison, median sensory to radial sensory comparison, mixed nerve comparison, and median motor testing. A review of these studies again could not determine conclusively that any of the electrodiagnostic tests was clearly superior ( 29 another evidence-based systematic review that examined 31 databases and 1,600 journals, found similar conclusions.
The 2002 publication of the AANEM, AAN, and AAPMR, whose protocol is preferred by the work group for electrodiagnostic testing, was an evidence-based review of 278 articles, of which 22 met literature inclusion criteria. This review also illustrated that there is no conclusive evidence that one single study has the highest sensitivity or specificity. It did, however, conclude that median sensory latencies across the wrist compared to ulnar or radial latencies or proximal median conduction improved sensitivity as opposed to absolute median sensory or motor distal latencies.
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Recommendation 3.3
The physician should not routinely evaluate patients suspected of having CTS with new technology such as magnetic resonance imaging (MRI), CT, and pressure-specified sensorimotor devices (PSSDs).
Level of Evidence: V Grade of Recommendation: C Changes in the appearance of the median nerve have been reported with MRI and CT. Following the face-to-face work group meeting on February 24, 2007, an additional nonsystematic literature review was completed. This review included 6 of 25 articles on MRI and no studies on CT. Five of the six articles on MRI were case-control study designs and therefore introduced spectrum bias. There is no good evidence to date that these imaging modalities improve sensitivity or specificity in making the diagnosis of CTS. 29 In the opinion of this committee, there is no role for the routine use of MRI or CT in the diagnosis or management of CTS. These imaging modalities should be reserved for the evaluation of related conditions in the appropriate clinical setting (eg, Kienböck disease, ruling out occult fracture, hook of hamate nonunion).
PSSDs have also been described for evaluation of patients with symptoms of CTS. Two of three studies investigating this technology were included in this additional literature review process. Two studies do not provide sufficient evidence to provide a recommendation. There is, however, significant experience and literature supporting the use of NCV/EMG in the evaluation of CTS. In the opinion of this committee, there is insufficient evidence to support the routine use of PSSDs in the evaluation of CTS at this time.
Future Research
Although every effort has been made to include studies of the highest evidence, high-quality evidence is not readily available for CTS diagnosis at this time. This guideline has been hindered by a relative lack of studies of the best design (ie, level I and II evidence) and specifically hindered by an abundance of case-control studies (which are subject to spectrum bias). To achieve a high-quality literature base, academic authors and scientists should invest their time and effort in studies designed to avoid bias (eg, blinded controlled trials that are not case-control studies). Future studies should, from the onset, be based on improved study design. The recommendations of this guideline have therefore depended to some degree on lesser evidence, including consensus and expert opinion. Few studies describe the impact of health policy on process optimization. Skillful and timely delivery of CTS care, the access that patients have to definitive management, and the choices patients make in the management of disease all affect outcomes. Studies of cost burden to the community from a common disabling source of productivity loss need restatement, and future studies must address all of these issues.
Although thousands of publications have been written regarding the diagnosis and treatment of CTS, greater precision and transparent methodology are needed to bring the next generation of academic papers to the forefront of review so that they directly contribute to quality medical care. The process of periodically assessing our medical and surgical progress in diagnosing and treating common conditions becomes more precise each year. A common protocol for evaluation of the literature should spur more consistently sound design and greater health for the cost of care expended. This clinical practice guideline is based on stronger evidence-based analysis methodology than ever previously conducted by the AAOS and is therefore state-of-the-art. The details of the statistical methods used in this guideline are further explained at http://www.aaos.org/Research/ guidelines/CTSdiagnosisguide.asp. 30 
